Drugs / AMBER GRISEA
last change Jan 2025 re-read 3 minutes ago

AMBER GRISEA

Developed for
autism spectrum disorder
Investigated by
Aditi Chadha

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT07054697 Jan 2017 → Dec 2024 autism spectrum disorder Aditi Chadha Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AMBER GRISEA “AMBER GRISEA” NCT07054697 ↗